GGrantIndex
Sort

17,828 grants matching crispr

Molecular Regulation of LDL Receptor Expression

$625,479
Brian T Emmer · University Of Michigan At Ann Arbor · R01 · FY2024 · HL

Neuropeptide S and arousal

$625,438
Luis De Lecea · Stanford University · R01 · FY2021 · MH

Multi-organism platform for functional assessment of human birth defect associated genomic variants

$625,432
Lilianna Solnica-Krezel · Washington University · R01 · FY2025 · HD

Synapse Engulfment by Oligodendrocyte Precursor Cells: A New Mechanism of Circuit Refinement in the Developing Brain

$625,414
Lucas M Cheadle · Cold Spring Harbor Laboratory · R01 · FY2024 · NS

Epigenetic mechanisms of sustained transcription across cocaine abstinence

$625,371
Elizabeth A Heller · University Of Pennsylvania · R01 · FY2025 · DA

Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies

$625,285
Joseph C Wu · Stanford University · R01 · FY2020 · HL

Cellular and Genetic Defects in Keratoconus

$625,118
Shukti Chakravarti · New York University School Of Medicine · R01 · FY2023 · EY

Single Cell Transcriptional and Epigenomic Dissection of Schizophrenia and Bipoloar Disease

$624,981
Manolis Kellis · Massachusetts Institute Of Technology · U01 · FY2019 · MH

CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD)

$624,920
Scott Q Harper · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AR

ANO5 in Muscle Health and Disease

$624,760
Renzhi Han · Ohio State University · R01 · FY2020 · HL

Uncovering the Molecular Determinants of Metastatic Recurrence and Impaired NK Cell Function

$624,724
Srinivas Malladi · Ut Southwestern Medical Center · R01 · FY2025 · CA

Targeting neuroblastoma cell state plasticity

$624,652
William A Weiss · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA

Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer

$624,587
Shiaowen David Hsu · Duke University · U01 · FY2022 · CA

Minimizing in vivo Drug Tolerance induction in tuberculosis.

$624,587
David G Russell · Rbhs-New Jersey Medical School · U19 · FY2022 · AI

Leveraging GWAS Findings to Map Variants and Identify Novel Effector Genes for Alcohol-Related Traits

$624,567
Henry Richard Kranzler · University Of Pennsylvania · R01 · FY2025 · AA

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Modeling BRAF-fusion driven pediatric brain tumors in the mouse

$624,546
Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Engineering T Cell Adoptive Therapy for Glioblastoma

$624,543
Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2024 · NS

FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma

$624,288
Richard D Kolodner · University Of California, San Diego · R01 · FY2025 · CA

Dysregulation of Histone Acetylation in Parkinson's Disease

$624,231
Frank Soldner · Albert Einstein College Of Medicine · R56 · FY2023 · NS

Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization

$624,204
Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2023 · HL

Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization

$624,204
Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · HL

Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization

$624,204
Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2021 · HL

Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization

$624,204
Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2022 · HL